Search Results

Keyword:accelerator

Lanzhou Taiji Completes Key Commissioning of First Domestic Multi-Ion Therapy Device HiTS400

Lanzhou Taiji Completes Key Commissioning of First Domestic Multi-Ion Therapy Device HiTS400

The first domestically produced multi-ion therapy device HiTS400, independently developed by Lanzhou Taiji and installed at Shandong Cancer Hospital, recently completed phased joint commissioning. After one week of operational testing, all beam parameters of the device met or exceeded contractual requirements, laying the foundation for subsequent clinical registration work. According to reports, HiTS400 is a medical ion accelerator independently developed by Lanzhou Taiji with full intellectual property rights. It can stably deliver four ion species: C^6+, H^+, He^2+, and O^8+, and is equipped with multi-angle fixed treatment nozzles and a lightweight superconducting heavy-ion rotating gantry, integrating modulated scanning technology to advance the development and application of multi-ion combined therapy devices. On August 14, 2026, the device obtained an amendment to its Radiation Safety License from the Ministry of Ecology and Environment, granting qualification for commissioning and operation. In the early morning of August 20, the equipment achieved stable acceleration and precise extraction of carbon ion beams. Measured data show that the particle number after synchrotron acceleration reached 3.26E9 ppp, the terminal particle number reached 3.02E9 ppp, the extraction efficiency was 92%, and beam stability was no less than 95%.

2026-08-26

South Korea's SEC Joins National R&D Project for Active Dose Distribution Control Radiotherapy Equipment

South Korea's SEC Joins National R&D Project for Active Dose Distribution Control Radiotherapy Equipment

South Korean electron beam source technology company SEC announced on August 25 that it has been selected as a joint research institution for the world's best active dose distribution control radiotherapy machine R&D project, and will participate in the development of core technologies related to next-generation radiotherapy equipment. The project is a newly established task under the Global Flagship Medical Device R&D Program of the South Korean government's medical device R&D fund, with a duration of 6 years and 6 months, starting from July this year and planned to continue until December 2032. The total project budget is 35.2 billion KRW, of which 28 billion KRW is government funding. Radexel serves as the lead institution, with SEC participating as a joint research institution. Other participating organizations include the Korea Atomic Energy Research Institute, Korea Testing Laboratory...

2026-08-25

German SIBAF Project Receives €9.7 Million to Support Fusion Materials Research

German SIBAF Project Receives €9.7 Million to Support Fusion Materials Research

On August 20, 2026, with funding from the German Federal Ministry of Research, Technology and Space (BMFTR), the SIBAF project will launch the construction of an accelerator infrastructure for fusion materials research. The project, whose full name is Superconducting Ion Accelerator as a Foundational Technology for Fusion Research, will receive €9.7 million over three years, of which €8.1 million is allocated to the GSI Helmholtz Centre for Heavy Ion Research (GSI) and its Facility for Antiproton and Ion Research (FAIR), currently under construction. Goethe University Frankfurt will also participate in the project. SIBAF is part of the funding program "Fusion Foundational Technologies — Toward the Fusion Power Plant." Project objectives...

2026-08-21

Construction of Radiotherapy and Radiosurgery Center Completed at Bulgaria's St. Ivan Rilski University Hospital

Construction of Radiotherapy and Radiosurgery Center Completed at Bulgaria's St. Ivan Rilski University Hospital

All construction and repair work for the new Radiotherapy and Radiosurgery Center at Bulgaria's St. Ivan Rilski University Hospital has been fully completed. According to the hospital, a latest-generation medical linear accelerator has been installed in the center, capable of sub-millimeter patient positioning accuracy. The equipment was delivered by the Ministry of Health under the National Recovery and Resilience Plan, as part of the investment project for the modernization of the national system for diagnosis and treatment of oncological diseases, funded by the European Commission's Recovery and Resilience Facility. The device is a TrueBeam-EDGE linear accelerator manufactured by Varian Medical Systems, equipped with BrainLab's ExactTrac Dynamic system, valued at 5.1 million...

2026-08-21

Five New Oncology Diagnostic and Treatment Devices at Bulgaria's ISUL Hospital Expected to Launch This Autumn

Five New Oncology Diagnostic and Treatment Devices at Bulgaria's ISUL Hospital Expected to Launch This Autumn

Queen Joanna - ISUL University Hospital in Bulgaria expects to begin operating five new devices for imaging diagnosis and treatment of oncological diseases starting early this autumn. The hospital stated that patients will be able to use these high-tech devices after the relevant licensing and approval procedures are completed. Source: Queen Joanna University Hospital - ISULThe newly added equipment is deployed in the imaging diagnostics department and the radiation oncology department. Among them, the radiation therapy department will be equipped with a TrueBeam v4.1 medical linear accelerator, primarily used for radiotherapy and radiosurgery. This device can deliver high-energy radiation to tumor tissue with greater precision, supporting high-precision dose planning to achieve the required therapeutic effect while minimizing radiation exposure to healthy tissues and organs surrounding the tumor.

2026-08-21

U.S. Department of Energy Selects Fermilab to Lead AI Project to Enhance Superconducting Radio-Frequency Cavity Control in Particle Accelerators

U.S. Department of Energy Selects Fermilab to Lead AI Project to Enhance Superconducting Radio-Frequency Cavity Control in Particle Accelerators

The U.S. Department of Energy's Genesis Program recently selected an artificial intelligence project led by Fermi National Accelerator Laboratory, supporting its collaboration with national laboratories, universities, and industry to use AI and machine learning technologies to improve resonance control in particle accelerators. The project aims to enhance accelerator operational performance and beam stability while reducing energy consumption and operating costs. Superconducting radio-frequency cavities are being assembled and tested, ready for installation on the Proton Improvement Plan-II at the Fermilab Accelerator Complex. By finely tuning the resonant frequency of the cavities, scientists can optimize acc...

2026-08-21

CERN Injector Complex Enters Final Beam Run Phase Before LS3

CERN Injector Complex Enters Final Beam Run Phase Before LS3

The CERN accelerator complex is entering its final operational phase before the third Long Shutdown (LS3). With the Large Hadron Collider (LHC) having already entered LS3, the injector complex and associated facilities will continue high-intensity beam operations until 6:00 a.m. on Monday, August 31, after which the operations team will hand over control to the LS3 coordination team, marking the formal transition of the entire accelerator complex into the shutdown maintenance phase. August 19, 2026, page one of the SPS. The third run of the injector complex is drawing to a close. (Image: CERN) During the final week-plus of operations, CERN will continue delivering proton and ion beams to physics experiments.

2026-08-21

Full-Life Technologies Completes Construction of Belgian Radiopharmaceutical Production Facility and Initiates Accelerator Commissioning

Full-Life Technologies Completes Construction of Belgian Radiopharmaceutical Production Facility and Initiates Accelerator Commissioning

Full-Life Technologies (hereinafter referred to as "Full-Life"), a privately held, fully integrated, clinical-stage international radiopharmaceutical therapy company, announced on August 20 that its radiopharmaceutical production facility in Gembloux, Belgium, has completed construction and received authorization to commence accelerator commissioning and enter the initial ramp-up phase. (Full-Life Technologies Belgium Radiopharmaceutical Production Facility) This milestone marks a significant step forward in Full-Life's vertically integrated radioisotope production capabilities moving toward formal operational status. With the completion of facility construction, the company has entered the next phase of operational preparation, including accelerator installation, phased commissioning, and validation of critical safety and operational systems.

2026-08-20

Berkeley Lab Leads Development of Portable Active-Source Muon Imager

Berkeley Lab Leads Development of Portable Active-Source Muon Imager

The U.S. Department of Energy's Lawrence Berkeley National Laboratory and Ideon Technologies have received funding from the DOE's Advanced Research Projects Agency-Energy (ARPA-E) to jointly develop a field-deployable active-source muon imaging technology through the Reliable Ore Characterization Using Cornerstone Sensing Technologies (ROCKS) program. The three-year project aims to enhance the detection and characterization of underground critical mineral resources. Image credit: Lawrence Berkeley National Laboratory. Muons are subatomic particles with strong penetrating capability. Previously, Ideon Technologies has used passive muons produced by cosmic rays in the atmosphere for ore body imaging in the mining sector, mapping mineral deposits and analyzing subsurface structures. However, passive muons primarily arrive from above, limiting detection angles; additionally, the natural flux is low—approximately one per square centimeter per minute—and imaging often requires days, weeks, or even months.

2026-08-20

Second Radiotherapy Linear Accelerator Commissioned at Buchholz Hospital in Germany

Second Radiotherapy Linear Accelerator Commissioned at Buchholz Hospital in Germany

The second medical linear accelerator for cancer radiotherapy at Buchholz Hospital in the North Heath region of Germany has been commissioned. The device was activated by the hospital's radiotherapy department under the direction of Chief Physician Dr. Günter Bohlen, marking a further enhancement of local oncological radiotherapy capabilities. The management of Buchholz Hospital and Winsen Hospital, Dr. Franziska von Brunnig (third from right) and Dr. Martin Meyer (first from right), together with Chief Physician Dr. Günter Bohlen (second from right) and the radiotherapy team, posed for a photo at the official commissioning ceremony of the second linear accelerator at Buchholz Hospital. Photo: Buchholz-Winsen Hospital. According to available information, Buchholz Hospital...

2026-08-20

German research team achieves ultra-compact plasma photocathode injection

German research team achieves ultra-compact plasma photocathode injection

A research team from institutions including the Helmholtz-Zentrum Dresden-Rossendorf in Germany has demonstrated an ultra-compact plasma photocathode injection scheme integrated into a hybrid plasma wakefield accelerator on the DRACO laser facility. The study utilized a 150 TW-class laser system to drive a laser wakefield accelerator (LWFA), generating high-peak-current electron beams, which in turn drove a subsequent particle beam wakefield accelerator (PWFA), completing the generation and acceleration of witness electron beams within millimeter-scale plasma structures. Plasma wakefield accelerators can produce accelerating fields far exceeding those of conventional radiofrequency linear accelerators, but how to obtain high-quality, high-brightness electron beams in compact devices...

2026-08-18

Korea's COSMAX Partners with Pohang Accelerator Laboratory to Use Synchrotron Radiation Accelerator for Cosmetics R&D

Korea's COSMAX Partners with Pohang Accelerator Laboratory to Use Synchrotron Radiation Accelerator for Cosmetics R&D

COSMAX, a global cosmetics ODM company, announced on the 18th that it has signed a memorandum of understanding with the Pohang Accelerator Laboratory (PAL) in Korea to conduct cosmetics R&D using advanced scientific and technological infrastructure such as the synchrotron radiation accelerator. At the MOU signing ceremony held at the Pohang Accelerator Laboratory, COSMAX Group Chairman Lee Kyung-soo (left) poses with PAL Director Kim Jae-young. / Photo provided by COSMAX. According to reports, the Pohang Synchrotron Radiation Accelerator (PLS-II) operated by the Pohang Accelerator Laboratory generates light more than 10 billion times brighter than sunlight, enabling atomic-scale analysis of nanoscale material structures. Currently, the facility has been used for microstructural research across multiple industrial fields, including new drugs, semiconductors, and new materials.

2026-08-18

World's first laser plasma accelerator-driven high-resolution muon imaging experiment to launch in Romania

World's first laser plasma accelerator-driven high-resolution muon imaging experiment to launch in Romania

Ideon Technologies, a global subsurface detection muon tomography company, is participating in an international research consortium to conduct the world's first high-resolution muon imaging experiment driven entirely by a laser plasma accelerator. The experiment aims to use a compact accelerator to produce muon beams on demand for non-destructive high-resolution imaging, with applications targeting mineral production, critical infrastructure, cargo inspection, medical imaging, semiconductors, nuclear security, and space radiation testing. Consortium members include the University of Texas at Austin, the Extreme Light Infrastructure - Nuclear Physics (ELI-NP) facility team, Heinrich Heine University Düsseldorf, Helmholtz-Zentrum Dresden-Rossendorf, ELI-Beamlines, and Tau Systems.

2026-08-18

SLAC team observes progressive melting of copper under extreme heat in real time

SLAC team observes progressive melting of copper under extreme heat in real time

Researchers at the SLAC National Accelerator Laboratory, under the U.S. Department of Energy, and their collaborators used the Mega-electron-volt Ultrafast Electron Diffraction (MeV-UED) facility to observe in real time the melting process of copper atoms under extreme temperatures. The study was published in Nature Communications. Future fusion power plants will need to replicate fusion reactions that occur inside stars here on Earth. The core plasma can reach temperatures of hundreds of millions of degrees Celsius, while surrounding structural materials must withstand sudden, intense thermal shocks. Copper and its alloys, owing to their excellent thermal conductivity, are considered capable of serving as "heat sinks" in fusion systems...

2026-08-15

Kazakhstan Enters a New Era of Atomic Energy, with the Institute of Nuclear Physics Viewed as a Key Pillar of the National Nuclear Industry

Kazakhstan Enters a New Era of Atomic Energy, with the Institute of Nuclear Physics Viewed as a Key Pillar of the National Nuclear Industry

Kazakhstan is entering a new stage of nuclear energy development. The construction of a nuclear power plant means not only the addition of a major energy project, but also the need for the country to simultaneously establish a complete nuclear industry system, including research support, personnel training, experimental infrastructure, nuclear and radiation safety systems, and indigenous technological capabilities. The article points out that a nuclear power plant can be built using foreign project designs, but true scientific and technological capability cannot be purchased along with the equipment; it is gradually formed through the long-term operation of nuclear facilities, conducting research, training engineering teams, and passing on experience. Against this backdrop, the Institute of Nuclear Physics of Kazakhstan is regarded as an important pillar of the future nuclear energy industry. The institution...

2026-08-14